On March 7, Mycenax Biotech announced a strategic partnership with Sartorius to jointly develop comprehensive biologics manufacturing solutions. This collaboration will leverage the core strengths of both companies to enhance service capabilities and expand their global market presence, delivering more efficient, flexible, and integrated CDMO services to clients worldwide.
Mycenax Biotech, a CDMO specializing in biologics, brings over 20 years of professional experience to the partnership. The company has successfully completed more than 150 projects involving process development and GMP manufacturing of protein-based drugs for global clients. Mycenax is renowned for its highly adaptable technical services and expertise in tailoring customized process solutions based on the unique characteristics of each biologic product.
Sartorius, headquartered in Germany, is a globally recognized supplier of biopharmaceutical manufacturing equipment and materials. Its CHO cell line platform has successfully supported the launch of seven new drugs and biosimilars worldwide, providing each with a high-quality, high-performance cell line foundation from early development through technology transfer and large-scale manufacturing.
Through this collaboration, Mycenax Biotech will expand its service scope by not only offering its existing high-efficiency cell line platforms but also seamlessly supporting global clients using Sartorius' CHO cell lines. Mycenax will provide end-to-end services, from raw material preparation and large-scale manufacturing to aseptic filling, accelerating the process of bringing protein therapeutics into clinical trials and onto the market.
This partnership represents more than just a convergence of technologies and resources—it demonstrates both companies' shared commitment to delivering exceptional service, fostering innovation, and promoting sustainable development. Mycenax and Sartorius aim to drive advancement in the biopharmaceutical industry, actively addressing global health needs and creating greater value in the field of biologics manufacturing.
Resource: 永昕生醫與Sartorius攜手合作 強化生物藥製程解決方案
